CEO, Resmed Inc.
SD 500 recap: As CEO for ResMed since 2013, Mick Farrell has led the company into a new data-driven, diagnostic era, establishing the company as a world leader in digital health with more than 8 million patients in its connected health ecosystem and more than 2.5 billion nights of medical sleep apnea and chronic obstructive pulmonary disease data. Before he joined the company, Farrell worked in management consulting, biotech, chemicals and metals manufacturing for Genzyme Corp., which is now part of Sanofi, the Dow Chemical Co., and BHP Billiton. He serves on the boards of the UC San Diego Foundation, San Diego Museum of Man and La Jolla Playhouse.
University of New South Wales, Massachusetts Institute of Technology
An avid fisherman, in 2018